US EditionKimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
The $48.7 billion deal combines top consumer health brands to create a company with approximately $32 billion in annual revenue, pending shareholder approval.
- In a Monday statement, Kimberly‑Clark Corp. said it will acquire Kenvue Inc., which makes Tylenol, in a $48.7 billion deal.
- After a months‑long strategic review that began in July, Kenvue Inc. was spun out of Johnson & Johnson in 2023 and faced leadership changes and mounting litigation risks, the Kenvue board said.
- The transaction is structured as cash plus stock, with Kenvue shareholders receiving $3.50 per share plus 0.14625 Kimberly‑Clark shares, implying $21.01 per share and a $40.32 billion equity value, while Kimberly‑Clark shareholders will own about 54% of the combined company.
- Kimberly‑Clark shares plunged 16% after the announcement, while Michael Hsu, Kimberly‑Clark chairman and chief executive officer, will lead the combined company; the deal is expected to close in the second half of next year.
- The deal also surfaced amid political scrutiny after President Donald Trump linked Tylenol to autism, which Kenvue disputed; the combined company will have roughly $32 billion in annual revenues.
177 Articles
177 Articles
Tylenol, Kleenex, Band-Aid, and more put under one roof in $48.7 billion consumer brands deal - The Boston Globe
The combined company will have a large stable of household brands under one roof, putting Kenvue’s Listerine mouthwash side-by-side with Kimberly-Clark’s Cottonelle toilet paper and Huggies.
Kimberly-Clark, the U.S. multinational consumer goods company with brands such as Kleenex or Huggies diapers, has agreed to purchase its rival Kenvue for about $40 billion, the equivalent of €34.720 billion, as reported by the companies through a statement.
KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama
It’s been a tough few weeks for the consumer health company Kenvue, after President Trump publicly spread unproven claims about Tylenol, one of its core subsidiary brands. Today, though, it seems like there might finally be some good news for Kenvue. This morning, Kimberly-Clark, the personal care corporation behind brands like Kleenex, Huggies, and Cottonelle, announced that it’s struck an agreement to acquire Kenvue (which, alongside Tylenol, …
Coverage Details
Bias Distribution
- 64% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
